Excessive opioid use and the development of chronic migraine.
Bigal
Marcelo E
ME
Global Director for Scientific Affairs, Merck Research Laboratories, Merck, Inc., 1 Merck Drive, Whitehouse Station, NJ 08889, USA Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA Montefiore Headache Center, Bronx, NY, USA Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Lipton
Richard B
RB
D000701:Analgesics, Opioid / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D064420:Drug-Related Side Effects and Adverse Reactions / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D008881:Migraine Disorders / Q000453:epidemiology* / Q000517:prevention & control*; D055656:Prescriptions / Q000706:statistics & numerical data*; D018570:Risk Assessment / Q000379:methods*
D000701:Analgesics, Opioid